-
Eli Lilly Direct-To-Consumer Push Shouldn't Worry Distributors: JPMorgan
Friday, March 7, 2025 - 10:07am | 449Read More...The rise of cash-pay GLP-1 prescriptions, fueled by programs like LillyDirect, is generating plenty of buzz—but JPMorgan analyst Lisa C. Gill isn't convinced this is a major shake-up for the healthcare supply chain. According to Gill, while Eli Lilly And Co's (NYSE:LLY) direct-to-consumer push is...
-
Bernie Sanders: 'Ozempic Will Likely Become One Of The Best-Selling Pharmaceutical Products In History' — Americans Shouldn't Pay 10-15X More
Wednesday, June 26, 2024 - 9:14pm | 623Read More...In a recent tweet, Bernie Sanders (I-Vt.) criticized the pricing of a popular diabetes drug, Ozempic, and its manufacturer, Novo Nordisk A/S (NYSE:NVO). What Happened: Sanders took to X, formerly Twitter, on Wednesday to express his concerns about the pricing of Ozempic. He suggested that the drug...
-
Blackstone's $18.7B E-Commerce Investment Is Largest Private Real Estate Transaction Ever
Monday, June 3, 2019 - 9:30am | 419Read More...Real estate investment firm Blackstone Group LP (NYSE: BX) said Sunday evening it reached an agreement to buy assets from Singapore-based GLP for $18.7 billion. What Happened Blackstone reached an agreement to acquire certain assets from three of GLP's U.S. funds which consist of 179 million...




